| 1 |
Kevin Osborn |
Capital One Services |
36 |
| 2 |
Arieh Don |
Emc Ip Holding Company |
33 |
| 3 |
Sorin Faibish |
Emc Ip Holding Company |
16 |
| #4 |
Clifton Forlines |
Tactual Labs |
14 |
| #5 |
Da Deng |
Sharkninja Operating |
13 |
| #6 |
Amihai Savir |
Emc Ip Holding Company |
11 |
| #6 |
Keith Newstadt |
Broadcom |
11 |
| #8 |
D. Travis Wilson |
Stealth Biotherapeutics |
10 |
| #8 |
Gregory Thomas Mark |
Markforged |
10 |
| #10 |
Carlo Giovanni Traverso |
MIT |
9 |
| #10 |
Timothy M. Swager |
MIT |
9 |
| #12 |
Anastasios John Hart |
MIT |
8 |
| #12 |
Stefano Di Cairano |
Mitsubishi Electric |
8 |
| #12 |
Vadim Lander |
Oracle |
8 |
| #15 |
Andrew D. Dominijanni |
Bose |
7 |
| #15 |
Douglas Hansell |
Baxter Healthcare Sa |
7 |
| #15 |
Mark J. Cartwright |
Harvard University |
7 |
| #15 |
Michel Bruehwiler |
Becton, Dickinson And |
7 |
| #15 |
Geoffrey M. Palmer |
PayPal |
7 |
| #15 |
Omid C. Farokhzad |
Brigham and Women's Hospital |
7 |
| #21 |
David R. Elmaleh |
The General Hospital |
6 |
| #21 |
Ebrahim Mehran Mestchian |
The Mathworks |
6 |
| #21 |
Udi Meirav |
Enverid Systems |
6 |
| #21 |
Xuri Gao |
Enanta Pharmaceuticals |
6 |
| #21 |
Robert Reimann |
Sonos |
6 |
| #21 |
Juejun Hu |
MIT |
6 |
| #21 |
Roman N. Litovsky |
Bose |
6 |
| #21 |
Randall M. Erb |
Northwestern University |
6 |
| #21 |
Patrick Robert Verhoest |
Pfizer |
6 |
| #30 |
Wei Lu |
Forma Therapeutics |
5 |
| #30 |
Renato Skerlj |
Anormed |
5 |
| #30 |
Kenneth P. Weiss |
Comcast |
5 |
| #30 |
Michael Aaron Brodney |
Pfizer |
5 |
| #30 |
Hudong Chen |
Dassault Systemes Simulia |
5 |
| #30 |
Glenn S. Benson |
JPMorgan Chase |
5 |
| #30 |
Mitri J. Abou-Rizk |
Abl Ip Holding |
5 |
| #30 |
Tatsuro Yoshida |
Hemanext |
5 |
| #30 |
Joseph Panarese |
Enanta Pharmaceuticals |
5 |
| #30 |
Joanne Kamens |
Rxi Pharmaceuticals |
5 |
| #40 |
Colin Whittaker |
Amazon |
4 |
| #40 |
Edward J. Olhava |
Epizyme |
4 |
| #40 |
Nicholas Dronen |
Here Global B.V. |
4 |
| #40 |
Denise E. Freed |
Schlumberger Technology |
4 |
| #40 |
Alexander Grinberg |
Depuy Synthes Products |
4 |
| #40 |
David J. Michael |
Cognex |
4 |
| #40 |
Andrew D. Levin |
Imbria Pharmaceuticals |
4 |
| #40 |
Tal Wenderow |
Corindus |
4 |
| #40 |
Marcus Williams |
Irobot |
4 |
| #40 |
Kevin J. Wilson |
Merck |
4 |
| #40 |
Loren D. Walensky |
Dana-Farber Cancer Institute |
4 |